Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation

BACKGROUND/AIMS: The dose of mycophenolate mofetil (MMF) has been reduced in Asia due to side effects associated with the conventional fixed dose of 2-3 g/day. We aimed to determine the pharmacokinetics of a reduced dose of MMF and to validate its feasibility in combination with tacrolimus in living...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyeyoung, Yi, Nam-Joon, Lee, Juyeun, Kim, Joohyun, Moon, Mi-Ra, Jeong, Jaehong, Lee, Jeong-Moo, You, Tae Suk, Suh, Suk-Won, Park, Min-Su, Choi, YoungRok, Hong, Geun, Lee, Hae Won, Lee, Kwang-Woong, Suh, Kyung-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197178/
https://www.ncbi.nlm.nih.gov/pubmed/25320733
http://dx.doi.org/10.3350/cmh.2014.20.3.291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197178/
https://www.ncbi.nlm.nih.gov/pubmed/25320733
http://dx.doi.org/10.3350/cmh.2014.20.3.291

Ejemplares similares